Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bofill

Showing results (571-580 of 594) with videos related to

Pageof 60
Sort By:
Plos One|October 21, 2014
The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapyAngelo Gámez-Pozo, Ramón M Pérez Carrión, Luis Manso, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2016
Defining the optimal sequence for the systemic treatment of metastatic breast cancerJ A Mestres, A B iMolins, L C Martínez, et al.
Frontiers in Oncology|May 10, 2021
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerTomás Pascual, Mafalda Oliveira, Eva Ciruelos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2023
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative studyM Oliveira, C Falato, J M Cejalvo, et al.
Human Mutation|December 12, 2023
Specifications of the ACMG/AMP Variant Classification Guidelines for Germline <i>DICER1</i> Variant CurationJessica N Hatton, Megan N Frone, Hannah C Cox, et al.
Hypertension (Dallas, Tex. : 1979)|May 12, 2022
Performance of a Multianalyte 'Rule-Out' Assay in Pregnant Individuals With Suspected PreeclampsiaMaged M Costantine, Baha Sibai, Allan T Bombard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 studyMiguel Martín, Amparo Ruiz, Manuel Ruiz Borrego, et al.
Helicobacter|April 19, 2026
Hope Hp-GC Project-Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin AmericaJavier Uribe, José Darío Portillo-Miño, Gonzalo Latorre, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2024
Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter StudyMegan M L Engels, Calise K Berger, Douglas W Mahoney, et al.
Fertility and Sterility|December 4, 2020
Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development studyJ M N Duffy, S Bhattacharya, S Bhattacharya, et al.
Pageof 60

Showing results (571-580 of 594) with videos related to

Sort By:
Pageof 60
Plos One|October 21, 2014
The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapyAngelo Gámez-Pozo, Ramón M Pérez Carrión, Luis Manso, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2016
Defining the optimal sequence for the systemic treatment of metastatic breast cancerJ A Mestres, A B iMolins, L C Martínez, et al.
Frontiers in Oncology|May 10, 2021
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerTomás Pascual, Mafalda Oliveira, Eva Ciruelos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2023
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative studyM Oliveira, C Falato, J M Cejalvo, et al.
Human Mutation|December 12, 2023
Specifications of the ACMG/AMP Variant Classification Guidelines for Germline <i>DICER1</i> Variant CurationJessica N Hatton, Megan N Frone, Hannah C Cox, et al.
Hypertension (Dallas, Tex. : 1979)|May 12, 2022
Performance of a Multianalyte 'Rule-Out' Assay in Pregnant Individuals With Suspected PreeclampsiaMaged M Costantine, Baha Sibai, Allan T Bombard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 studyMiguel Martín, Amparo Ruiz, Manuel Ruiz Borrego, et al.
Helicobacter|April 19, 2026
Hope Hp-GC Project-Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin AmericaJavier Uribe, José Darío Portillo-Miño, Gonzalo Latorre, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2024
Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter StudyMegan M L Engels, Calise K Berger, Douglas W Mahoney, et al.
Fertility and Sterility|December 4, 2020
Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development studyJ M N Duffy, S Bhattacharya, S Bhattacharya, et al.
Pageof 60